ABT-239 from BOC Sciences

Supplier Page

Supplier Page from
BOC Sciences for
ABT-239

Description

ABT-239 is a novel, highly efficacious, non-imidazole class of H3R antagonist has been investigated as a treatment for ADHD, Alzheimer's disease, and schizophrenia